Prostate Cancer Outcomes – Compare & Reduce Variation in Prostate Cancer Centers certified by the German Cancer Society; subproject MID-EPIC-D

Prostate Cancer Outcomes – Compare & Reduce Variation in Prostate Cancer Centers certified by the German Cancer Society; subproject MID-EPIC-D - PCO-D

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010774

Enrollment

150000

Registered

2016-09-08

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Prostate cancer patients are surveyed pre- and posttherapeutically (EPIC-26 and additional items) to identify differences in outcomes across centers. Additional clinical parameters are collec

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with localized prostate cancer

Exclusion criteria

Exclusion criteria: insufficient language skills to fill out questionnaire

Design outcomes

Primary

Measure	Time frame
1. (relative) survival, 2. disease-free survival, 3. PROs: 3a. incontinence, 3b. irritative/obstructive, 3c. gastrointestinal, 3d. sexuality, 3e. hormonal, and 3f. libido, collected after 6 and 12 months, then annually	—

Secondary

Measure	Time frame
formative evaluation of data collection method	—

Countries

Austria, Germany, Luxembourg, Switzerland

Contacts

Public ContactChristoph Kowalski

Deutsche Krebsgesellschaft

kowalski@krebsgesellschaft.de0049-30-322932947

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 6, 2026